INCR Valuation

InterCure Ltd

Add to Watchlist

Advanced Chart

1.325

0.000(0.000%)

Overview
Forecast
Valuation

INCR Relative Valuation

INCR's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, INCR is overvalued; if below, it's undervalued.

Historical Valuation

InterCure Ltd (INCR) is now in the Undervalued zone, suggesting that its current forward PS ratio of 0.69 is considered Undervalued compared with the five-year average of 1.44. The fair price of InterCure Ltd (INCR) is between 1.34 to 4.65 according to relative valuation methord. Compared to the current price of 1.32 USD , InterCure Ltd is Undervalued By 1.21%.

Relative Value

Fair Zone

1.34-4.65

Current Price：1.32

1.21%

Undervalued

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

0.49

P/B

Median3y

0.94

Median5y

1.47

0.00

FCF Yield

Median3y

-1.54

Median5y

-2.02

Competitors Valuation Multiple

The average P/S ratio for INCR's competitors is 1.80, providing a benchmark for relative valuation. InterCure Ltd Corp (INCR) exhibits a P/S ratio of 0.69, which is -61.57% above the industry average. Given its robust revenue growth of 7.52%, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

Revenue Growth

Market Cap